Clinical outcomes of transjugular intrahepatic portosystemic shunt for portal hypertension: Korean multicenter real-practice data
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김형기 | - |
dc.contributor.author | 김윤준 | - |
dc.contributor.author | 정우진 | - |
dc.contributor.author | 김순선 | - |
dc.contributor.author | 심재준 | - |
dc.contributor.author | 최문석 | - |
dc.contributor.author | 김도영 | - |
dc.contributor.author | 전대원 | - |
dc.contributor.author | 엄순호 | - |
dc.contributor.author | 박성재 | - |
dc.contributor.author | 우현영 | - |
dc.contributor.author | 정영걸 | - |
dc.contributor.author | 백순구 | - |
dc.contributor.author | 김문영 | - |
dc.contributor.author | 박수영 | - |
dc.contributor.author | 이재명 | - |
dc.contributor.author | 김영석 | - |
dc.date.accessioned | 2022-07-16T05:37:44Z | - |
dc.date.available | 2022-07-16T05:37:44Z | - |
dc.date.created | 2021-05-13 | - |
dc.date.issued | 2014-03 | - |
dc.identifier.issn | 2287-2728 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/160461 | - |
dc.description.abstract | Background/Aims: This retrospective study assessed the clinical outcome of a transjugular intrahepaticportosystemic shunt (TIPS) procedure for managing portal hypertension in Koreans with liver cirrhosis. Methods: Between January 2003 and July 2013, 230 patients received a TIPS in 13 university-based hospitals. Results: Of the 229 (99.6%) patients who successfully underwent TIPS placement, 142 received a TIPS for varicealbleeding, 84 for refractory ascites, and 3 for other indications. The follow-up period was 24.9±30.2 months (mean±SD),74.7% of the stents were covered, and the primary patency rate at the 1-year follow-up was 78.7%. Hemorrhageoccurred in 30 (21.1%) patients during follow-up; of these, 28 (93.3%) cases of rebleeding were associated with stentdysfunction. Fifty-four (23.6%) patients developed new hepatic encephalopathy, and most of these patients weresuccessfully managed conservatively. The cumulative survival rates at 1, 6, 12, and 24 months were 87.5%, 75.0%,66.8%, and 57.5%, respectively. A high Model for End-Stage Liver Disease (MELD) score was significantly associatedwith the risk of death within the first month after receiving a TIPS (P=0.018). Old age (P<0.001), indication for a TIPS(ascites vs. bleeding, P=0.005), low serum albumin (P<0.001), and high MELD score (P=0.006) were associated withoverall mortality. Conclusions: A high MELD score was found to be significantly associated with early and overall mortality rate in TIPSpatients. Determining the appropriate indication is warranted to improve survival in these patients. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | 대한간학회 | - |
dc.title | Clinical outcomes of transjugular intrahepatic portosystemic shunt for portal hypertension: Korean multicenter real-practice data | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 전대원 | - |
dc.identifier.doi | 10.3350/cmh.2014.20.1.18 | - |
dc.identifier.scopusid | 2-s2.0-84921425089 | - |
dc.identifier.bibliographicCitation | Clinical and Molecular Hepatology, v.20, no.1, pp.18 - 27 | - |
dc.relation.isPartOf | Clinical and Molecular Hepatology | - |
dc.citation.title | Clinical and Molecular Hepatology | - |
dc.citation.volume | 20 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 18 | - |
dc.citation.endPage | 27 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART001859126 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordPlus | adolescent | - |
dc.subject.keywordPlus | adult | - |
dc.subject.keywordPlus | aged | - |
dc.subject.keywordPlus | Asian continental ancestry group | - |
dc.subject.keywordPlus | clinical trial | - |
dc.subject.keywordPlus | end stage liver disease | - |
dc.subject.keywordPlus | female | - |
dc.subject.keywordPlus | follow up | - |
dc.subject.keywordPlus | Hemorrhage | - |
dc.subject.keywordPlus | hepatic encephalopathy | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | Hypertension, Portal | - |
dc.subject.keywordPlus | Kaplan Meier method | - |
dc.subject.keywordPlus | male | - |
dc.subject.keywordPlus | middle aged | - |
dc.subject.keywordPlus | mortality | - |
dc.subject.keywordPlus | multicenter study | - |
dc.subject.keywordPlus | pathology | - |
dc.subject.keywordPlus | retrospective study | - |
dc.subject.keywordPlus | risk | - |
dc.subject.keywordPlus | risk factor | - |
dc.subject.keywordPlus | severity of illness index | - |
dc.subject.keywordPlus | South Korea | - |
dc.subject.keywordPlus | survival rate | - |
dc.subject.keywordPlus | transjugular intrahepatic portosystemic shunt | - |
dc.subject.keywordPlus | treatment outcome | - |
dc.subject.keywordPlus | university hospital | - |
dc.subject.keywordPlus | very elderly | - |
dc.subject.keywordPlus | young adult | - |
dc.subject.keywordAuthor | Liver cirrhosis | - |
dc.subject.keywordAuthor | Transjugular intrahepatic portosystemic shunt | - |
dc.subject.keywordAuthor | Portal hypertension | - |
dc.identifier.url | https://www.e-cmh.org/journal/view.php?doi=10.3350/cmh.2014.20.1.18 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.